IMO-2125 Induces Endogenous Interferons and Other Antiviral Proteins - News) today presents preclinical data on the mechanism by which IMO-2125 was shown to induce immune activation through Toll-like Receptor 9 (TLR9).... [read full story]
|
RELATED
|
|
IMO-2125 Induces Endogenous Interferons and Other Antiviral Proteins - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 3, 2009 - Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today presents preclinical data on the mechanism by which...
Tim Sullivan, Ambulatory Health Care, Medicines & Remedies, Scientific Discoveries, Health Care, Pharmaceuticals, Anti-virals, Infections, Patients, Medical Research, Replicon
